Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD146 antigen (MCAM) is a cell adhesion molecule belonging to the immunoglobulin superfamily. It is a transmembrane glycoprotein involved in cell adhesion, endothelial cell function, angiogenesis, and metastasis. It is highly expressed in melanoma and sarcoma, making it a diagnostic marker and potential therapeutic target.
Monoclonal antibodies against CD146 can inhibit its function or be used for targeted drug delivery. Soluble CD146 can modulate gene transcription.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD146 antigen (CD146).